Nde-Eshimuni M Salema1, Rachel A Elliott, Cris Glazebrook. 1. School of Pharmacy, Division of Social Research in Medicines and Health, The University of Nottingham, Nottingham, UK. Ndeshi.Salema@nottingham.ac.uk
Abstract
PURPOSE: To assess the effectiveness of adherence-enhancing interventions (AEIs) aimed at adolescents (10-19-year-olds). METHODS: An extensive search of seven bibliographic databases was conducted at the end of 2009 to identify comparative studies evaluating AEIs targeting adolescents. Data describing study characteristics and intervention effects on adherence to medicines or health outcomes were extracted and summarized using qualitative and quantitative methods. RESULTS: A total of 17 AEIs were identified: 12 studies (70%) were conducted in the United States, 10 (59%) included adolescents with type 1 diabetes mellitus, and 14 (82%) considered the developmental tasks of adolescence. In all, 12 AEIs successfully improved outcome measures. Features of successful interventions included targeting AEIs to a narrow age range, including family in type 1 diabetes mellitus management, and improving access to care. Poor quality and underpowered studies limit the inferences drawn from this review. CONCLUSIONS: More diverse and robust studies are needed to identify strategies to help adolescents manage medicines.
PURPOSE: To assess the effectiveness of adherence-enhancing interventions (AEIs) aimed at adolescents (10-19-year-olds). METHODS: An extensive search of seven bibliographic databases was conducted at the end of 2009 to identify comparative studies evaluating AEIs targeting adolescents. Data describing study characteristics and intervention effects on adherence to medicines or health outcomes were extracted and summarized using qualitative and quantitative methods. RESULTS: A total of 17 AEIs were identified: 12 studies (70%) were conducted in the United States, 10 (59%) included adolescents with type 1 diabetes mellitus, and 14 (82%) considered the developmental tasks of adolescence. In all, 12 AEIs successfully improved outcome measures. Features of successful interventions included targeting AEIs to a narrow age range, including family in type 1 diabetes mellitus management, and improving access to care. Poor quality and underpowered studies limit the inferences drawn from this review. CONCLUSIONS: More diverse and robust studies are needed to identify strategies to help adolescents manage medicines.
Authors: Sumaira Malik; Sinead NiMhurchadha; Christina Jackson; Lina Eliasson; John Weinman; Sandrine Roche; John Walter Journal: JIMD Rep Date: 2014-09-12
Authors: Natalie Walders-Abramson; Elizabeth M Venditti; Carolyn E Ievers-Landis; Barbara Anderson; Laure El Ghormli; Mitchell Geffner; Joan Kaplan; Michaela B Koontz; Ron Saletsky; Marisa Payan; Patrice Yasuda Journal: J Pediatr Date: 2014-06-16 Impact factor: 4.406
Authors: George C Patton; Susan M Sawyer; John S Santelli; David A Ross; Rima Afifi; Nicholas B Allen; Monika Arora; Peter Azzopardi; Wendy Baldwin; Christopher Bonell; Ritsuko Kakuma; Elissa Kennedy; Jaqueline Mahon; Terry McGovern; Ali H Mokdad; Vikram Patel; Suzanne Petroni; Nicola Reavley; Kikelomo Taiwo; Jane Waldfogel; Dakshitha Wickremarathne; Carmen Barroso; Zulfiqar Bhutta; Adesegun O Fatusi; Amitabh Mattoo; Judith Diers; Jing Fang; Jane Ferguson; Frederick Ssewamala; Russell M Viner Journal: Lancet Date: 2016-05-09 Impact factor: 79.321